A systematic review - Biologically-based complementary medicine use by people living with cancer – is a more clearly defined role for the pharmacist required?

Research in Social and Administrative Pharmacy - Tập 13 - Trang 1037-1044 - 2017
Trong Quy Le1, Lorraine Smith1, Joanna Harnett1
1Faculty of Pharmacy, University of Sydney, NSW 2006, Australia

Tài liệu tham khảo

World Health Organisation. Essential Medicines and Health Products. Available at: http://www.who.int/medicines/areas/traditional/definitions/en/(accessed on 01/06/16). U.S National Library of Medicine. Complementary and Alternative Medicine. Available at: https://www.nlm.nih.gov/tsd/acquisitions/cdm/subjects24.html (accessed on 01/06/16). Verhoef, 2005, Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review, Integr Cancer Ther, 4, 274, 10.1177/1534735405282361 Werneke, 2004, Potential health risks of complementary alternative medicines in cancer patients, Br J Cancer, 90, 408, 10.1038/sj.bjc.6601560 Davis, 2012, Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review, Oncol, 17, 1475, 10.1634/theoncologist.2012-0223 Sullivan, 2015, Complementary and Alternative Medicine Use in Cancer patients in rural Australia, Integr Cancer Ther, 14, 350, 10.1177/1534735415580679 Shih, 2009, Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients, Ann Oncol, 20, 752, 10.1093/annonc/mdn659 Chrystal, 2003, The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre, N. Z Med J, 116, U296 Ustundag, 2015, Complementary and alternative medicine use among Cancer patients and determination of affecting factors: a questionnaire study, Holist Nurs Pract, 29, 357, 10.1097/HNP.0000000000000113 Edwards, 2014, Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy, Asia Pac J Clin Oncol, 10, 346, 10.1111/ajco.12203 Lawenda, 2008, Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?, J Natl Cancer Inst, 100, 773, 10.1093/jnci/djn148 Pathak, 2005, Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non-small cell lung cancer, J Am Coll Nutr, 24, 16, 10.1080/07315724.2005.10719438 Braun, 2015, vol. 2, 150 Kang, 2015, Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin, Exp Biol Med (Maywood, NJ), 240, 1416, 10.1177/1535370215571881 Pihlak, 2014, Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling, Eur J Cancer Care, 23, 24954, 10.1111/ecc.12132 Lee, 2014, National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer, J Clin Oncol, 32, 4095, 10.1200/JCO.2014.55.8676 Frenkel, 2014, Effective communication about the use of complementary and integrative medicine in cancer care, J Altern Complement Med (New York, NY), 20, 12, 10.1089/acm.2012.0533 Koh, 2003, Pharmacists' patterns of use, knowledge, and attitudes toward complementary and alternative medicine, J Altern Complement Med (New York, NY), 9, 51, 10.1089/107555303321222946 Braun, 2014, Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients, Asia Pac J Clin Oncol, 10, 289, 10.1111/ajco.12227 Bozza, 2015, Complementary and alternative medicine in oncology, Recenti Prog Med, 106, 601 Dissiz, 2016, Complementary and alternative therapies and health literacy in cancer patients, Complement Ther Clin Pract, 23, 34, 10.1016/j.ctcp.2016.02.004 Rausch, 2011, Complementary and alternative medicine: use and disclosure in radiation oncology community practice, Support Care Cancer, 19, 521, 10.1007/s00520-010-0846-5 Corina, 2016, Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients, A Qual anal Suppor, 1 King, 2015, Surveys of Cancer patients and Cancer health care providers regarding complementary therapy use, communication, and information needs, Integr Cancer Ther, 14, 515, 10.1177/1534735415589984 Ben-Arye, 2016, Communication and integration: a qualitative analysis of perspectives among Middle Eastern oncology healthcare professionals on the integration of complementary medicine in supportive cancer care, J Cancer Res Clin Oncol, 142, 1117, 10.1007/s00432-016-2120-9 Dahlhaus, 2015, Complementary medicine for cancer patients in general practice: qualitative interviews with german general practitioners, Forsch Komplementmed, 22, 36 Nightingale, 2015, A pharmacist led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer, J Geriatr Oncol, 6, 411, 10.1016/j.jgo.2015.07.003 Thakerar, 2014, Pharmacist advice on the safety of Complementary and Alternative Medicines during conventional anticancer treatment, J Pharm Pract Res, 44, 231, 10.1002/jppr.1031 Naidu, 2005, Attitudes of Australian pharmacists toward complementary and alternative medicines, Ann Pharmacother, 39, 1456, 10.1345/aph.1G089